Option Care Health (NASDAQ:OPCH) Sees Strong Trading Volume on Better-Than-Expected Earnings

Shares of Option Care Health, Inc. (NASDAQ:OPCH) saw unusually-strong trading volume on Tuesday after the company announced better than expected quarterly earnings. Approximately 1,565,199 shares were traded during mid-day trading, an increase of 27% from the previous session’s volume of 1,232,796 shares.The stock last traded at $30.46 and had previously closed at $30.41.

The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. The business had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business’s quarterly revenue was up 12.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.21 EPS.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on OPCH shares. Barrington Research restated an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research note on Wednesday. Jefferies Financial Group boosted their price target on Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of the stock in a transaction dated Monday, February 26th. The stock was purchased at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the transaction, the director now owns 269,528 shares of the company’s stock, valued at $8,503,608.40. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Mutual of America Capital Management LLC lifted its position in Option Care Health by 63.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 190,684 shares of the company’s stock worth $6,424,000 after buying an additional 73,938 shares during the last quarter. Wellington Management Group LLP lifted its position in Option Care Health by 15.9% in the third quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company’s stock worth $93,698,000 after buying an additional 397,627 shares during the last quarter. HealthInvest Partners AB bought a new stake in Option Care Health in the fourth quarter worth $1,254,000. Ontario Teachers Pension Plan Board bought a new stake in Option Care Health in the third quarter worth $546,000. Finally, Van ECK Associates Corp lifted its position in Option Care Health by 244.2% in the third quarter. Van ECK Associates Corp now owns 34,291 shares of the company’s stock worth $1,109,000 after buying an additional 24,328 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Performance

The company has a debt-to-equity ratio of 0.74, a current ratio of 1.77 and a quick ratio of 1.33. The business has a 50-day moving average of $32.04 and a 200-day moving average of $31.50. The company has a market capitalization of $5.09 billion, a P/E ratio of 19.27, a P/E/G ratio of 1.74 and a beta of 1.22.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.